Literature DB >> 19461911

On the path to standardizing esophageal cancer treatment in Japan.

Taroh Satoh1, Yuh Sakata.   

Abstract

Entities:  

Year:  2009        PMID： 19461911      PMCID： PMC2684721     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  19 in total

1.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

Review 2.  Early gastric cancer: diagnosis, pathology, treatment techniques and treatment outcomes.

Authors:  Hiroyuki Ono
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-08       Impact factor: 2.566

3.  Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.

Authors:  Kohei Shitara; Kei Muro
Journal:  Gastrointest Cancer Res       Date:  2009-03

4.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors.

Authors:  Y Tajima; Y Nakanishi; A Ochiai; Y Tachimori; H Kato; H Watanabe; H Yamaguchi; K Yoshimura; M Kusano; T Shimoda
Journal:  Cancer       Date:  2000-03-15       Impact factor: 6.860

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

7.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

Authors:  Bryan H Burmeister; B Mark Smithers; Val Gebski; Lara Fitzgerald; R John Simes; Peter Devitt; Stephen Ackland; David C Gotley; David Joseph; Jeremy Millar; John North; Euan T Walpole; James W Denham
Journal:  Lancet Oncol       Date:  2005-09       Impact factor: 41.316

8.  Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases.

Authors:  Takako Eguchi; Yukihiro Nakanishi; Tadakazu Shimoda; Motoki Iwasaki; Hiroyasu Igaki; Yuji Tachimori; Hoichi Kato; Hajime Yamaguchi; Daizo Saito; Satoshi Umemura
Journal:  Mod Pathol       Date:  2006-03       Impact factor: 7.842

Review 9.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Esophageal cancer. Clinical practice guidelines in oncology.

Authors:  Jaffer Ajani; Thomas A D'Amico; James A Hayman; Neal J Meropol; Bruce Minsky
Journal:  J Natl Compr Canc Netw       Date:  2003-01       Impact factor: 11.908
View more
  3 in total

1.  Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.

Authors:  Nobuhiro Ueno; Akio Shimizu; Michiyuki Kanai; Yugo Iwaya; Shugo Ueda; Jun Nakayama; Misuzu Kurokawa Seo
Journal:  J Histochem Cytochem       Date:  2015-10-20       Impact factor: 2.479

2.  Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study.

Authors:  Ken Kato; Takashi Ura; Wasaburo Koizumi; Satoru Iwasa; Chikatoshi Katada; Mizutomo Azuma; Satoshi Ishikura; Yoshinori Nakao; Hiroshi Onuma; Kei Muro
Journal:  Cancer Sci       Date:  2018-02-15       Impact factor: 6.716

Review 3.  A long-surviving patient with advanced esophageal basaloid squamous cell carcinoma treated only with radiotherapy: case report and literature review.

Authors:  Toshiya Maebayashi; Naoya Ishibashi; Takuya Aizawa; Masakuni Sakaguchi; Homma Taku; Moritaka Ohhara; Toshirou Takimoto; Yoshiaki Tanaka
Journal:  BMC Gastroenterol       Date:  2017-12-08       Impact factor: 3.067
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.